New research explains why metastatic uveal melanoma is resistant to conventional immunotherapies and how adoptive therapy, which involves growing a patient’s T cells outside the body before reinfusing them, can successfully treat this rare and aggressive cancer.
Lesen Sie weiter auf: New insights could unlock immunotherapy for rare, deadly eye cancer
Quelle: ScienceDaily | Immune System
Titelbild/Grafik by ScienceDaily News
Kommentare und Fragen
Möchten Sie zu diesem Artikel ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!Weiteres von ScienceDaily | Allergy
- Activation of innate immunity: Important piece of the puzzle identified
- Gene signatures from tissue-resident T cells as a predictive tool for melanoma patients
- Scientists identify new brain circuit in mice that controls body's inflammatory reactions
- New mRNA cancer vaccine triggers fierce immune response to fight malignant brain tumor
- Regulating cholesterol levels might be the key to improving cancer treatment
- Experimental type 1 diabetes drug shelters pancreas cells from immune system attack
- Component of keto diet plus immunotherapy may reduce prostate cancer
- Pregnancy cytokine levels impact fetal brain development and offspring behavior
- Vitamin D alters mouse gut bacteria to give better cancer immunity
- How immune cells communicate to fight viruses
